Nevada Cannabis: 103 Stores, 100% Resident Capture, and the Post-Capture Revenue Decline

Nevada's cannabis market peaked at $965 million in FY22 and has declined 28% to a $695 million annualized pace. But the decline isn't a failure — it's what happens after you've already captured every gram of resident demand and prices keep falling.

Market Overview

Nevada legalized adult-use cannabis under Question 2 in November 2016. First recreational sales began July 1, 2017 — one of the fastest ballot-to-sales timelines in the country. The market operates under the Cannabis Compliance Board (CCB), established in 2019 under Assembly Bill 533.

Key metrics:

• 103 dispensaries statewide (102 combined medical/adult-use + 1 standalone medical)
• 387 total operational licenses (128 cultivation, 100 production, 103 retail, 46 distribution, 8 labs, 2 consumption lounges)
• FY24 total taxable sales: $829.2 million (July 2023 – June 2024)
• FY25 total taxable sales: $757.7 million (-8.6% YoY)
• $5.11/g blended flower (May 2024, Metrc volume-weighted average)
• $6.36/g ordinary flower eighth ($22.27 per eighth)
• 100% estimated resident capture at FY24 pricing

Flower Pricing

Nevada's pricing data comes from the Cannabis Policy Institute at UNLV's "Overview of the 2024 Nevada Cannabis Economy," an analysis of anonymized Metrc track-and-trace data. The report breaks out pricing by product tier — ordinary flower and small buds ("popcorn") are tracked separately, and the blended average reflects volume-weighted sales across all flower categories:

The volume-weighted blended average across both tiers is $5.11/g as of May 2024, declining from $6.18/g in May 2023 — a 17% year-over-year drop. The decline fits a near-perfect linear trend (R² = 0.98) of approximately 9.5 cents per month.

Prices have likely compressed further since this data was collected. Carson City dispensaries currently advertise ounces at $110 ($3.93/g), and ordinary flower YoY declines were accelerating at -21% by April-May 2024.

These are pre-tax prices. After Nevada's consumer-facing taxes (10% retail excise + ~8.375% sales tax), out-the-door pricing for an ordinary flower eighth in Clark County runs approximately $26-27 (~$7.50/g). Strip-adjacent dispensaries charge tourist premiums well above this — $10+/g is common.

Nevada achieves 100% capture at a higher pre-tax price than Colorado ($3.18), Oregon ($3.33), or Michigan ($2.96) — and despite carrying one of the heaviest tax burdens in the country. The difference is geography: 89% of Nevada's population is concentrated in two metro areas (Clark and Washoe counties), producing effective competitive density that far exceeds the statewide 3.2 dispensaries per 100K.

Tax Structure

Nevada's cannabis tax structure is among the heaviest in the country:

• 15% wholesale excise tax on fair market value of cannabis transferred from cultivation to production or distribution (applies to both adult-use and medical — unusual among legal states)
• 10% retail excise tax on retail sales of adult-use cannabis
• Standard sales tax (~8.375% in Clark County, varies by jurisdiction)

The combined effective tax burden in Clark County runs ~27% — the 15% wholesale excise amounts to roughly 8.8% of the retail price since it's levied on the lower wholesale value, plus 10% retail excise and ~8.375% sales tax.

Medical cannabis is subject to the 15% wholesale excise but exempt from the 10% retail excise. Medical patients still pay standard sales tax.

Despite this heavy burden, Nevada achieved full capture. This is possible because the pre-tax wholesale price ($10.42/eighth for ordinary flower, $8.15 for smalls) is low enough that even after 33% in taxes, the out-the-door price for small buds competes with illicit alternatives. The tax burden inflates the price — it doesn't prevent capture when the underlying wholesale cost is competitive.

Total Addressable Market

Nevada's population is approximately 3.2 million. Applying the empirically validated consumption baseline of 18% participation at 1.0 gram per day:

• 2.46 million adults 21+
• 443,500 estimated regular consumers (18%)
• 162 million grams annual demand (443,500 × 365)

At the $5/g commodity endgame, Nevada's resident TAM is $809 million. FY24 revenue of $829 million — generated at $5.11/g blended pricing — implies approximately 162 million grams sold, matching the TAM estimate within rounding. FY24 represents 100% estimated resident capture, with the ~$20 million surplus attributable to tourism.

Revenue: The Post-Capture Decline

Nevada Department of Taxation cannabis revenue reports show a market in sustained decline:

Revenue has declined 28% from peak while visitor volume to Las Vegas increased from ~35 million (FY22 average) to ~41 million (FY24). Tourism went up. Cannabis revenue went down. Per-visitor cannabis spending declined from $27.57 to $18.94 — a 31% drop driven entirely by price compression. Tourists are still buying; they're just paying less per gram.

The FY26 acceleration in revenue decline (-8.3%) does correlate with the first significant tourism decline since the pandemic recovery — Las Vegas visitor volume dropped 7-9% in the first half of 2025. But the structural story is price compression outrunning volume growth in a market that has already captured all available resident demand.

This is the Colorado trajectory. Colorado's revenue declined from $1.9 billion at ~$9/g to $1.6 billion at ~$3/g despite selling three times more product. Nevada is following the same curve — but starting from a smaller base and with 89% of its population concentrated in two metros.

Geographic Concentration

Nevada's revenue breakdown by county reveals a market that mirrors its population distribution almost exactly:

Clark County's revenue share has been converging toward its population share:

The tourism premium has evaporated. In FY26, Clark County generates revenue exactly proportional to its population. Las Vegas dispensaries are no longer outperforming the rest of the state — they're serving locals at the same per-capita rate as Reno and rural Nevada.

This concentration is also why 103 stores achieves what takes Colorado 900: 89% of the population lives in two metro areas. A Las Vegas resident has 10+ dispensaries within a 15-minute drive. The effective competitive density where people actually live is far higher than the statewide 3.2 per 100K figure implies.

Dispensary Density

Nevada's $8.05M per-store revenue is the second-highest in the country behind Maryland — driven by population concentration, not tourism. At 4.2 per 100K, Nevada achieves full capture at lower density than any other state in this dataset. Colorado needed 20 per 100K. Massachusetts needed 7.2. Nevada did it at 4.2 because its population geography eliminates the rural access problem that plagues other states.

What the CHS Literature Missed

The Nevada Cannabis Compliance Board's consumer page covers safe consumption, youth prevention, secondhand smoke risks, child safety, and titration guidance ("start with a small amount"). The CCB's required product label warnings list overconsumption symptoms as "nausea, vomiting, anxiety, agitation, paranoia, and psychosis" — all framed as dose-related effects.

CHS does not appear on the consumer page, in the FAQ, in the required warning labels, or in any CCB public health bulletin. The regulator overseeing 443,500 regular consumers across 103 dispensaries does not reference CHS in its public-facing health guidance. A Reno emergency physician at Renown Medical Center described CHS as "not overly common," noting it "affects some people and doesn't affect the majority of everyone else."

If CHS affected 17-33% of daily users as some clinical estimates suggest, Nevada's consumer base would include 37,000-73,000 sufferers. At that prevalence, Clark County emergency departments — already strained by 41 million annual tourists — would be seeing thousands of CHS presentations monthly. The CCB's omission of CHS from its consumer health materials reflects what the case volume data actually shows: a syndrome rare enough that the state's own compliance board does not consider it a public health priority warranting consumer-facing disclosure.

Home Cultivation

Nevada permits home cultivation of up to six plants per person (12 per household) only if no licensed retail cannabis store exists within 25 miles of the residence. With 103 dispensaries concentrated in Clark and Washoe counties, this effectively prohibits home grow for nearly the entire population. As observed in every market that allows home grow, the revenue impact is negligible — and in Nevada's case, it's negligible by statute for nearly everyone.

The Bottom Line

Nevada is the proof of concept for what happens after full capture. The market captured 100% of resident demand by FY24 through competitive pricing ($5.11/g blended) at remarkably low store density (4.2 per 100K), enabled by geographic concentration — 89% of the population in two metro areas.

The 28% revenue decline from FY22's $965 million peak is not a crisis. It is price compression doing exactly what it does in every maturing agricultural commodity market: driving per-unit revenue down while total volume holds steady. Tourism, which contributed a modest share of total revenue, has provided a cushion that is now eroding as Las Vegas visitor volume declines in 2025.

The $5/g commodity endgame TAM for Nevada residents is approximately $809 million. Revenue is already below that at the current $695 million pace, meaning prices have compressed below $5/g in much of the state — consistent with the $3.93/g ounces currently available in Carson City. The market is approaching its natural floor: the price at which legal operators can cover production costs, taxes, and a minimal margin. At that point, revenue stabilizes and the narrative shifts from growth to margin management — a transition that Colorado, Oregon, and now Nevada have made, and that every other legal market will eventually face.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.